Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rubella Susceptibility in Multiparous Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00401505
Recruitment Status : Completed
First Posted : November 20, 2006
Last Update Posted : February 22, 2019
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

Brief Summary:
The purpose of this study is to determine the reasons why multiparous women (women who are pregnant and have been pregnant before) might still be susceptible to rubella.

Condition or disease
Rubella Vaccine

Detailed Description:
This study is designed to investigate why multiparous women might still be susceptible to rubella. All pregnant women are checked for rubella immunity, and if they are non-immune, there are standard orders in our hospital to administer the rubella vaccine on the post-partum floor prior to discharge home from the hospital. Despite this, some multiparous women are found to be susceptible (non-immune), and this study will explore the reasons for this.

Layout table for study information
Study Type : Observational
Actual Enrollment : 310 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Rubella Susceptibility in Multiparous Women
Study Start Date : September 2006
Actual Primary Completion Date : September 2012
Actual Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rubella





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All rubella susceptible women who delivered during the study period.
Criteria

Inclusion Criteria:

  • All rubella susceptible women who delivered during the study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00401505


Locations
Layout table for location information
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Layout table for investigator information
Principal Investigator: Mark H Yudin, MD, MSc St. Michael's Hospital, Toronto
Layout table for additonal information
Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT00401505    
Other Study ID Numbers: 06-186
First Posted: November 20, 2006    Key Record Dates
Last Update Posted: February 22, 2019
Last Verified: February 2019
Keywords provided by St. Michael's Hospital, Toronto:
rubella
rubella vaccine
postpartum
immunity
Additional relevant MeSH terms:
Layout table for MeSH terms
Rubella
Rubivirus Infections
Togaviridae Infections
RNA Virus Infections
Virus Diseases